Mechanical homeostasis is altered in uterine leiomyoma.

PubWeight™: 1.22‹?› | Rank: Top 10%

🔗 View Article (PMC 2696475)

Published in Am J Obstet Gynecol on April 01, 2008

Authors

Rebecca Rogers1, John Norian, Minnie Malik, Gregory Christman, Mones Abu-Asab, Faye Chen, Casey Korecki, James Iatridis, William H Catherino, Rocky S Tuan, Namisha Dhillon, Phyllis Leppert, James H Segars

Author Affiliations

1: Reproductive Biology and Medicine Branch, NICHD, NIH, Bethesda, MD 20892, USA.

Articles citing this

Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev (2013) 1.91

New directions in the epidemiology of uterine fibroids. Semin Reprod Med (2010) 1.58

Brx mediates the response of lymphocytes to osmotic stress through the activation of NFAT5. Sci Signal (2009) 1.30

Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas. Reprod Sci (2009) 1.09

Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations. Hum Reprod Update (2014) 0.98

Characterization of tissue biomechanics and mechanical signaling in uterine leiomyoma. Matrix Biol (2011) 0.97

1,25-dihydroxyvitamin d3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells. Biol Reprod (2013) 0.92

Leiomyoma: genetics, assisted reproduction, pregnancy and therapeutic advances. J Assist Reprod Genet (2012) 0.91

Proceedings from theNational Institute of Child Health and Human Development conference on the Uterine Fibroid Research Update Workshop. Fertil Steril (2011) 0.88

Magnetic resonance elastography of uterine leiomyomas: a feasibility study. Fertil Steril (2010) 0.87

Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction. Obstet Gynecol Int (2013) 0.87

Gonadotropin-releasing hormone agonist increases expression of osmotic response genes in leiomyoma cells. Fertil Steril (2011) 0.86

Integrin β1 regulates leiomyoma cytoskeletal integrity and growth. Matrix Biol (2012) 0.85

Extracellular matrix collagen alters cell proliferation and cell cycle progression of human uterine leiomyoma smooth muscle cells. PLoS One (2013) 0.85

Stromal fibroblast activation and their potential association with uterine fibroids (Review). Oncol Lett (2014) 0.81

The extracellular matrix contributes to mechanotransduction in uterine fibroids. Obstet Gynecol Int (2014) 0.79

Dynamic reciprocity between cells and their microenvironment in reproduction. Biol Reprod (2014) 0.78

Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy. Mol Med (2015) 0.78

Role of activin-A and myostatin and their signaling pathway in human myometrial and leiomyoma cell function. J Clin Endocrinol Metab (2014) 0.78

Chromodomain helicase binding protein 8 (Chd8) is a novel A-kinase anchoring protein expressed during rat cardiac development. PLoS One (2012) 0.77

Collagen-binding α11 integrin expression in human myometrium and fibroids utilizing a novel RNA in situ probe. Reprod Sci (2014) 0.77

Mechanical signaling in reproductive tissues: mechanisms and importance. Reprod Sci (2014) 0.77

Injectable Clostridium histolyticum collagenase as a potential treatment for uterine fibroids. Reprod Sci (2014) 0.77

Activating transcription factor 3 gene expression suggests that tissue stress plays a role in leiomyoma development. Fertil Steril (2008) 0.77

The Guanine Nucleotide Exchange Factor Brx: A Link between Osmotic Stress, Inflammation and Organ Physiology and Pathophysiology. Expert Rev Endocrinol Metab (2010) 0.77

Expression of a mitochondrial progesterone receptor (PR-M) in leiomyomata and association with increased mitochondrial membrane potential. J Clin Endocrinol Metab (2014) 0.76

A Proteomic Approach for the Identification of Up-Regulated Proteins Involved in the Metabolic Process of the Leiomyoma. Int J Mol Sci (2016) 0.76

Matrix production and remodeling as therapeutic targets for uterine leiomyoma. J Cell Commun Signal (2014) 0.76

Structural insights into the activation of the RhoA GTPase by the lymphoid blast crisis (Lbc) oncoprotein. J Biol Chem (2014) 0.76

Regulation of adipose oestrogen output by mechanical stress. Nat Commun (2013) 0.76

Use of dietary phytochemicals to target inflammation, fibrosis, proliferation, and angiogenesis in uterine tissues: promising options for prevention and treatment of uterine fibroids? Mol Nutr Food Res (2014) 0.76

Leiomyoma cells in 3-dimensional cultures demonstrate an attenuated response to fasudil, a rho-kinase inhibitor, when compared to 2-dimensional cultures. Reprod Sci (2014) 0.76

Perineal leiomyoma in a postmenopausal woman: A case report. Oncol Lett (2016) 0.75

Leiomyoma-derived transforming growth factor-β impairs bone morphogenetic protein-2-mediated endometrial receptivity. Fertil Steril (2015) 0.75

Sample size calculation for microarray experiments with blocked one-way design. BMC Bioinformatics (2009) 0.75

A Role for Progesterone-Regulated sFRP4 Expression in Uterine Leiomyomas. J Clin Endocrinol Metab (2017) 0.75

Articles cited by this

Tensional homeostasis and the malignant phenotype. Cancer Cell (2005) 19.30

Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev (2002) 6.54

Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc Natl Acad Sci U S A (1998) 5.34

p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature (2007) 4.63

Selected methods for imaging elastic properties of biological tissues. Annu Rev Biomed Eng (2003) 4.54

Functional tissue engineering of articular cartilage through dynamic loading of chondrocyte-seeded agarose gels. J Biomech Eng (2000) 4.22

A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem (1996) 4.03

Rho GTPases are over-expressed in human tumors. Int J Cancer (1999) 3.70

The tension mounts: mechanics meets morphogenesis and malignancy. J Mammary Gland Biol Neoplasia (2004) 3.54

Exploring the neighborhood: adhesion-coupled cell mechanosensors. Cell (2002) 3.15

Uterine fibroids: the elephant in the room. Science (2005) 3.12

Filamin is essential in actin cytoskeletal assembly mediated by p21-activated kinase 1. Nat Cell Biol (2002) 2.45

Cell tension, matrix mechanics, and cancer development. Cancer Cell (2005) 2.42

Mechanotransduction: all signals point to cytoskeleton, matrix, and integrins. Sci STKE (2002) 2.36

Endogenous nitric oxide mechanisms mediate the stretch dependence of Ca2+ release in cardiomyocytes. Nat Cell Biol (2001) 2.14

Rho/Rho-kinase mediated signaling in physiology and pathophysiology. J Mol Med (Berl) (2002) 2.03

Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. Cardiovasc Res (2000) 2.00

Identification of filamin as a novel ligand for caveolin-1: evidence for the organization of caveolin-1-associated membrane domains by the actin cytoskeleton. Mol Biol Cell (2000) 1.90

Sphingosylphosphorylcholine regulates keratin network architecture and visco-elastic properties of human cancer cells. Nat Cell Biol (2003) 1.84

Conditional ROCK activation in vivo induces tumor cell dissemination and angiogenesis. Cancer Res (2004) 1.81

Initiation and transduction of stretch-induced RhoA and Rac1 activation through caveolae: cytoskeletal regulation of ERK translocation. J Biol Chem (2003) 1.73

Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids. Genes Chromosomes Cancer (2004) 1.65

A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays. Am J Obstet Gynecol (2006) 1.60

Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometrium. Fertil Steril (2004) 1.27

Calcium-sensing receptor activation of rho involves filamin and rho-guanine nucleotide exchange factor. Endocrinology (2002) 1.24

Subcutaneous tissue mechanical behavior is linear and viscoelastic under uniaxial tension. Connect Tissue Res (2003) 1.14

Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. J Soc Gynecol Investig (2003) 1.13

Characterization of Brx, a novel Dbl family member that modulates estrogen receptor action. Oncogene (1998) 1.12

Association of Lbc Rho guanine nucleotide exchange factor with alpha-catenin-related protein, alpha-catulin/CTNNAL1, supports serum response factor activation. J Biol Chem (2002) 1.08

Strategy for elucidating differentially expressed genes in leiomyomata identified by microarray technology. Fertil Steril (2003) 1.05

Novel method to characterize primary cultures of leiomyoma and myometrium with the use of confirmatory biomarker gene arrays. Fertil Steril (2007) 0.99

Rho family Guanine nucleotide exchange factor Brx couples extracellular signals to the glucocorticoid signaling system. J Biol Chem (2006) 0.99

The proto-oncoprotein Brx activates estrogen receptor beta by a p38 mitogen-activated protein kinase pathway. J Biol Chem (2001) 0.99

The Rho guanine nucleotide exchange factor AKAP13 (BRX) is essential for cardiac development in mice. J Biol Chem (2010) 0.97

A comparative analysis of structure and spatial distribution of decorin in human leiomyoma and normal myometrium. Biochim Biophys Acta (2003) 0.95

Extracellular matrix components in uterine leiomyoma and their alteration during the tumour growth. Mol Cell Biochem (1998) 0.92

Human uterine leiomyomata express higher levels of peroxisome proliferator-activated receptor gamma, retinoid X receptor alpha, and all-trans retinoic acid than myometrium. Cancer Res (1999) 0.87

Expression of brx proto-oncogene in normal ovary and in epithelial ovarian neoplasms. Am J Obstet Gynecol (2000) 0.86

Identification, quantification and fine structural characterization of glycosaminoglycans from uterine leiomyoma and normal myometrium. Biochimie (2001) 0.84

The concentrations of collagen-associated amino acids are higher in GnRH agonist-treated uterine myomas. Obstet Gynecol (1993) 0.82

Identification of the major proteoglycans from human myometrium. Acta Obstet Gynecol Scand (2001) 0.78

Articles by these authors

Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol (2012) 4.72

Electrospun nanofibrous structure: a novel scaffold for tissue engineering. J Biomed Mater Res (2002) 4.71

Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther (2007) 3.97

Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells (2007) 3.79

Characterization of the apical papilla and its residing stem cells from human immature permanent teeth: a pilot study. J Endod (2008) 2.95

Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem (2004) 2.71

The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol (2011) 2.47

Pathological findings in a patient with Fabry disease who died after 2.5 years of enzyme replacement. Virchows Arch (2005) 2.45

Comparison of minimally invasive direct anterior versus posterior total hip arthroplasty based on inflammation and muscle damage markers. J Bone Joint Surg Am (2011) 2.37

Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. FASEB J (2004) 2.30

Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk. J Biol Chem (2003) 2.25

Interobserver and intraobserver variability in the histological dating of the endometrium in fertile and infertile women. Fertil Steril (2004) 2.22

Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res (2002) 2.18

Multilineage differentiation of human mesenchymal stem cells in a three-dimensional nanofibrous scaffold. Biomaterials (2005) 2.18

Increasing survival of ischemic tissue by targeting CD47. Circ Res (2007) 2.16

Fabrication and characterization of six electrospun poly(alpha-hydroxy ester)-based fibrous scaffolds for tissue engineering applications. Acta Biomater (2006) 2.14

Adhesion formation after laparoscopic excision of endometriosis and lysis of adhesions. Fertil Steril (2005) 2.08

Biological response of chondrocytes cultured in three-dimensional nanofibrous poly(epsilon-caprolactone) scaffolds. J Biomed Mater Res A (2003) 2.07

Stem/progenitor cell-mediated de novo regeneration of dental pulp with newly deposited continuous layer of dentin in an in vivo model. Tissue Eng Part A (2010) 2.06

Proficiency in oocyte retrieval: how many procedures are necessary for training? Fertil Steril (2011) 2.04

Transient exposure to transforming growth factor beta 3 under serum-free conditions enhances the biomechanical and biochemical maturation of tissue-engineered cartilage. Tissue Eng Part A (2008) 1.95

Human marrow-derived mesenchymal progenitor cells: isolation, culture expansion, and analysis of differentiation. Mol Biotechnol (2002) 1.90

Concise review: the surface markers and identity of human mesenchymal stem cells. Stem Cells (2014) 1.89

Engineering on the straight and narrow: the mechanics of nanofibrous assemblies for fiber-reinforced tissue regeneration. Tissue Eng Part B Rev (2009) 1.88

Regulation of MMP-13 expression by RUNX2 and FGF2 in osteoarthritic cartilage. Osteoarthritis Cartilage (2004) 1.87

Major biological obstacles for persistent cell-based regeneration of articular cartilage. Arthritis Res Ther (2007) 1.85

Embryo afterloading: a refinement in embryo transfer technique that may increase clinical pregnancy. Fertil Steril (2005) 1.84

Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells. Arthritis Rheum (2008) 1.83

Characterization of multipotential mesenchymal progenitor cells derived from human trabecular bone. Stem Cells (2003) 1.82

MicroRNAs and cell differentiation in mammalian development. Birth Defects Res C Embryo Today (2006) 1.78

Identification and functional analysis of candidate genes regulating mesenchymal stem cell self-renewal and multipotency. Stem Cells (2006) 1.78

Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther (2008) 1.75

iPS cells reprogrammed from human mesenchymal-like stem/progenitor cells of dental tissue origin. Stem Cells Dev (2010) 1.73

Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis. J Cell Physiol (2010) 1.68

Technology insight: adult mesenchymal stem cells for osteoarthritis therapy. Nat Clin Pract Rheumatol (2008) 1.67

Technology Insight: adult stem cells in cartilage regeneration and tissue engineering. Nat Clin Pract Rheumatol (2006) 1.66

Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids. Genes Chromosomes Cancer (2004) 1.65

Mechanoactive tenogenic differentiation of human mesenchymal stem cells. Tissue Eng Part A (2008) 1.63

Endometrial shedding effect on conception and live birth in women with polycystic ovary syndrome. Obstet Gynecol (2012) 1.62

A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays. Am J Obstet Gynecol (2006) 1.60

Cartilage tissue engineering: its potential and uses. Curr Opin Rheumatol (2006) 1.59

Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation. Blood (2006) 1.56

The prevalence of genuine empty follicle syndrome. Fertil Steril (2011) 1.54

Chondrocyte phenotype in engineered fibrous matrix is regulated by fiber size. Tissue Eng (2006) 1.54

Cross-talk between Wnt signaling pathways in human mesenchymal stem cells leads to functional antagonism during osteogenic differentiation. J Cell Biochem (2007) 1.52

Nanobiomaterial applications in orthopedics. J Orthop Res (2007) 1.51

Mesenchymal stem cell therapy for attenuation of scar formation during wound healing. Stem Cell Res Ther (2012) 1.48

Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling. Trends Endocrinol Metab (2002) 1.47

Are there subtle genome-wide epigenetic alterations in normal offspring conceived by assisted reproductive technologies? Fertil Steril (2011) 1.47

Interleukin-6 maintains bone marrow-derived mesenchymal stem cell stemness by an ERK1/2-dependent mechanism. J Cell Biochem (2009) 1.47

Canonical and non-canonical Wnts differentially affect the development potential of primary isolate of human bone marrow mesenchymal stem cells. J Cell Physiol (2007) 1.46

Comparison of assisted reproductive technology utilization and outcomes between Caucasian and African American patients in an equal-access-to-care setting. Fertil Steril (2006) 1.46

Transient exposure to transforming growth factor beta 3 improves the mechanical properties of mesenchymal stem cell-laden cartilage constructs in a density-dependent manner. Tissue Eng Part A (2009) 1.43

Preconception stress and the secondary sex ratio: a prospective cohort study. Fertil Steril (2012) 1.42

Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity? J Clin Endocrinol Metab (2004) 1.38

Human mesenchymal progenitor cell-based tissue engineering of a single-unit osteochondral construct. Tissue Eng (2004) 1.34

Epidemiology of myomas. Obstet Gynecol Clin North Am (2006) 1.33

Stem/progenitor cells from inflamed human dental pulp retain tissue regeneration potential. Regen Med (2010) 1.32

Regional multilineage differentiation potential of meniscal fibrochondrocytes: implications for meniscus repair. Anat Rec (Hoboken) (2007) 1.30

Distinct functions of BMP4 and GDF5 in the regulation of chondrogenesis. J Cell Biochem (2004) 1.30

Brx mediates the response of lymphocytes to osmotic stress through the activation of NFAT5. Sci Signal (2009) 1.30

Differentiation potential of multipotent progenitor cells derived from war-traumatized muscle tissue. J Bone Joint Surg Am (2008) 1.28

Comparative evaluation of MSCs from bone marrow and adipose tissue seeded in PRP-derived scaffold for cartilage regeneration. Biomaterials (2012) 1.28

Interaction of cartilage oligomeric matrix protein/thrombospondin 5 with aggrecan. J Biol Chem (2007) 1.27

Analysis of N-cadherin function in limb mesenchymal chondrogenesis in vitro. Dev Dyn (2002) 1.27

Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometrium. Fertil Steril (2004) 1.27

CD47 deficiency confers cell and tissue radioprotection by activation of autophagy. Autophagy (2012) 1.27

Glucocorticoids promote chondrogenic differentiation of adult human mesenchymal stem cells by enhancing expression of cartilage extracellular matrix genes. Stem Cells (2006) 1.26

Characterization of an animal model of aggressive metastatic pheochromocytoma linked to a specific gene signature. Clin Exp Metastasis (2009) 1.26

Wnt-3A enhances bone morphogenetic protein-2-mediated chondrogenesis of murine C3H10T1/2 mesenchymal cells. J Biol Chem (2002) 1.25

Blocking thrombospondin-1/CD47 signaling alleviates deleterious effects of aging on tissue responses to ischemia. Arterioscler Thromb Vasc Biol (2007) 1.25

Mitochondria directly donate their membrane to form autophagosomes during a novel mechanism of parkin-associated mitophagy. Cell Biosci (2014) 1.24

Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts. Ann Surg (2008) 1.24

Detection of periprosthetic infections with use of ribosomal RNA-based polymerase chain reaction. J Bone Joint Surg Am (2010) 1.23

Reconstitution of marrow-derived extracellular matrix ex vivo: a robust culture system for expanding large-scale highly functional human mesenchymal stem cells. Stem Cells Dev (2010) 1.22

Modulation of osteogenesis in human mesenchymal stem cells by specific pulsed electromagnetic field stimulation. J Orthop Res (2009) 1.22

Hypertrophy in mesenchymal stem cell chondrogenesis: effect of TGF-beta isoforms and chondrogenic conditioning. Cells Tissues Organs (2010) 1.21

A prospective assessment of the predictive value of basal antral follicles in in vitro fertilization cycles. Fertil Steril (2003) 1.20

Intervertebral disc tissue engineering using a novel hyaluronic acid-nanofibrous scaffold (HANFS) amalgam. Tissue Eng Part A (2008) 1.20

Effects of TGF-beta1 and triiodothyronine on cartilage maturation: in vitro analysis using long-term high-density micromass cultures of chick embryonic limb mesenchymal cells. J Orthop Res (2006) 1.20

Putative heterotopic ossification progenitor cells derived from traumatized muscle. J Orthop Res (2009) 1.20

Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene. J Clin Endocrinol Metab (2008) 1.19

Concise review: the clinical application of mesenchymal stem cells for musculoskeletal regeneration: current status and perspectives. Stem Cells Transl Med (2012) 1.19

Concise review: clinical translation of wound healing therapies based on mesenchymal stem cells. Stem Cells Transl Med (2011) 1.19

Influence of decellularized matrix derived from human mesenchymal stem cells on their proliferation, migration and multi-lineage differentiation potential. Biomaterials (2012) 1.18

Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical cushing syndrome: a clinical and molecular genetic investigation. J Clin Endocrinol Metab (2005) 1.18

Current state of cartilage tissue engineering. Arthritis Res Ther (2003) 1.17

Interobserver and intraobserver variation in day 3 embryo grading. Fertil Steril (2006) 1.16

Intervertebral disc cell response to dynamic compression is age and frequency dependent. J Orthop Res (2009) 1.16

Notochordal cell conditioned medium stimulates mesenchymal stem cell differentiation toward a young nucleus pulposus phenotype. Stem Cell Res Ther (2010) 1.16

Effects of commercial anthocyanin-rich extracts on colonic cancer and nontumorigenic colonic cell growth. J Agric Food Chem (2004) 1.16

In vivo response of polylactic acid-alginate scaffolds and bone marrow-derived cells for cartilage tissue engineering. Tissue Eng (2005) 1.14

Mesenchymal stem cells inhibit both endogenous and exogenous MMPs via secreted TIMPs. J Cell Physiol (2011) 1.14

Novel strategies in tendon and ligament tissue engineering: Advanced biomaterials and regeneration motifs. Sports Med Arthrosc Rehabil Ther Technol (2010) 1.14

Regulation of the chondrogenic phenotype in culture. Birth Defects Res C Embryo Today (2009) 1.13

Comparative gene expression profiling of normal and degenerative discs: analysis of a rabbit annular laceration model. Spine (Phila Pa 1976) (2002) 1.12

Cell delivery therapeutics for musculoskeletal regeneration. Adv Drug Deliv Rev (2010) 1.10

Evaluation of articular cartilage repair using biodegradable nanofibrous scaffolds in a swine model: a pilot study. J Tissue Eng Regen Med (2009) 1.10